Biotech & Life Sciences hub: 131 startups and 88 funds matched in our directory. Search the full startup corpus from /startups.
Venture Capital Tracker logo
Venture Capital Tracker

Biotech & Life Sciences startups and investors we cover

Shortlist companies and funds tagged Biotech & Life Sciences in our directory. This hub is a sector cut, not a complete market census. Search every startup from /startups or open the investor list.

Startups in this sector

Showing 12 of 131 matched profiles.

  • NewLimit

    Therapeutics developer pursuing epigenetic reprogramming of aged cells.

  • Delix Therapeutics

    Clinical-stage neuroscience biotech developing non-hallucinogenic neuroplastogen medicines.

  • Chai Discovery

    AI molecular-design company licensing research models and tools to pharmaceutical teams.

  • Isomorphic Labs

    AI-first pharmaceutical research company combining molecular design models, pharma collaborations and an internal therapeutic pipeline.

  • Mirendil

    Mirendil builds Lor, a private-beta multi-agent AI research workspace, and Fern; it disclosed a $200M June 2026 seed and a separate $1B November Series A.

  • Boltz

    MIT-founded biotech applying open AI protein models to lab deployment (public-benefit corp).

  • BigHat Biosciences

    AI-guided antibody design platform (Milliner) for safer protein therapeutics.

  • Formation Bio

    AI-native pharma company in-licensing and accelerating clinical-stage drug development.

  • Tiny Health

    Microbiome testing and intelligence platform with at-home gut and vaginal health products; raised $33M Series B led by B Capital in September 2026.

  • Varda Space Industries

    Microgravity-enabled life-sciences company manufacturing pharmaceutical materials in orbit and returning them to Earth.

  • Osmo

    AI-powered digital olfaction — fragrance design via molecular data and machine learning.

  • Century Health

    AI platform structuring real-world clinical data for pharma R&D and outcomes research.

Investors in this sector

Showing 12 of 88 matched funds.

  • 4BIO Capital

    London-based life-sciences venture capital firm focused on advanced therapies, including cell and gene therapy, RNA medicines, targeted therapies and the microbiome.

  • Abstract Ventures

    Abstract is a San Francisco venture capital firm investing across seed and early-stage technology companies. The firm reports $3.3 billion in assets under management and participated in Volantis's $88 million Series A.

  • AgriZeroNZ

    New Zealand agritech investment company focused on technologies that can reduce agricultural greenhouse-gas emissions. It led ArkeaBio’s $15 million Series A2 in September 2026.

  • Alta Partners

    Alta Partners is a U.S. venture capital firm focused on life sciences and healthcare companies, investing across company formation and clinical development.

  • Alumni Ventures

    Founded in 2014, Alumni Ventures is a US co-investor participating alongside lead VCs across early and later-stage rounds. It publishes $100K–$10M company checks (typically $1M–$3M), does not lead or take board seats, and reports 1,800+ historical portfolio companies. Separately, it manages diversified and focused venture products for eligible investors; cumulative commitments are not the same as AUM.

  • Arboretum Ventures

    Ann Arbor healthcare VC founded 2002. Manages ~$1B across six funds; Fund VI closed at $268M (June 2023). Focus: medical devices, life science tools & diagnostics, tech-enabled care, pharma adjacencies — with preference for under-ventured geographies including the Midwest. Main office: First National Building, 201 S. Main Street, Suite 300, Ann Arbor, MI 48104.

  • ARCH Venture Partners

    ARCH Venture Partners is a Chicago-based investor that creates and backs science-driven companies, especially in biotechnology and medicine. It often works with researchers to turn discoveries into businesses. Its investment approach focuses on scientific proof, development milestones and commercialization.

  • AstraZeneca Ventures

    Corporate venture and strategic investment activity associated with AstraZeneca, focused on biotechnology, therapeutics, diagnostics, digital health and technologies that can improve drug development and manufacturing.

  • Atlas Venture

    Atlas Venture is a Cambridge, Massachusetts firm that creates and backs early-stage biotechnology companies. It often incubates or co-founds businesses built around new medicines and scientific discoveries. Its portfolio spans therapeutics developers from company formation through clinical development and exits.

  • AVP

    Global investment platform backing technology and life-sciences companies across venture, growth and other private-market strategies.

  • Bain Capital Life Sciences

    Bain Capital Life Sciences invests in biotechnology, pharmaceuticals, medical devices, diagnostics and life-science tools. It co-led OMass Therapeutics’ $310M Series C announced on October 15, 2026, alongside Forbion and Novo Holdings. It is distinct from Bain Capital Ventures.

  • BioGenerator Ventures

    St. Louis company-creation and early-stage investor focused on healthcare and agriculture. Part of the BioSTL ecosystem; BioGenerator dates to 2003 as a regional life-science formation engine. BioGenerator Ventures builds companies from concepts/EIRs, invests from an evergreen model, and syndicates with national venture and strategic capital. Sectors: therapeutics, diagnostics, research tools, and agtech. HQ St. Louis, MO.